Literature DB >> 11544286

Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice.

M I Rossi1, K L Medina, K Garrett, G Kolar, P C Comp, L D Shultz, J D Capra, P Wilson, A Schipul, P W Kincade.   

Abstract

Human B lineage lymphocyte precursors in chimeric nonobese diabetic/SCID mice transplanted with umbilical cord blood cells were directly compared with those present in normal bone marrow. All precursor subsets were represented and in nearly normal proportions. Cell cycle activity and population dynamics were investigated by staining for the Ki-67 nuclear Ag as well as by incorporation experiments using 5-bromo-2'-deoxyuridine. Again, this revealed that human B lymphopoiesis in chimeras parallels that in normal marrow with respect to replication and progression through the lineage. Moreover, sequencing of Ig gene rearrangement products showed that a diverse repertoire of V(H) genes was utilized by the newly formed lymphocytes but there was no evidence for somatic hypermutation. The newly formed B cells frequently acquired the CD5 Ag and had a short life span in the periphery. Thus, all molecular requirements for normal B lymphocyte formation are present in nonobese diabetic/SCID mice, but additional factors are needed for recruitment of B cells into a fully mature, long-lived pool. The model can now be exploited to learn about species restricted and conserved environmental cues for human B lymphocyte production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544286     DOI: 10.4049/jimmunol.167.6.3033

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model.

Authors:  Ana Paula D N de Barros; Christina M Takiya; Luciana R Garzoni; Mona Lisa Leal-Ferreira; Hélio S Dutra; Luciana B Chiarini; Maria Nazareth Meirelles; Radovan Borojevic; Maria Isabel D Rossi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 2.  Use of humanized severe combined immunodeficient mice for human vaccine development.

Authors:  Gloria C Koo; Aisha Hasan; Richard J O'Reilly
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

3.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.

Authors:  Diana M Brainard; Edward Seung; Nicole Frahm; Annaiah Cariappa; Charles C Bailey; William K Hart; Hae-Sook Shin; Sarah F Brooks; Heather L Knight; Quentin Eichbaum; Yong-Guang Yang; Megan Sykes; Bruce D Walker; Gordon J Freeman; Shiv Pillai; Susan V Westmoreland; Christian Brander; Andrew D Luster; Andrew M Tager
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

4.  Human B-cell ontogeny in humanized NOD/SCID γc(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire.

Authors:  H Chang; S Biswas; A S Tallarico; P T N Sarkis; S Geng; M M Panditrao; Q Zhu; W A Marasco
Journal:  Genes Immun       Date:  2012-05-17       Impact factor: 2.676

5.  Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse.

Authors:  Gregory C Ippolito; Kam Hon Hoi; Sai T Reddy; Sean M Carroll; Xin Ge; Tobias Rogosch; Michael Zemlin; Leonard D Shultz; Andrew D Ellington; Carla L Vandenberg; George Georgiou
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  A novel clinically relevant graft-versus-leukemia model in humanized mice.

Authors:  Bei Jia; Chenchen Zhao; Michael Bayerl; Hiroko Shike; David F Claxton; W Christopher Ehmann; Shin Mineishi; Todd D Schell; Pan Zheng; Yi Zhang; Leonard D Shultz; K Sandeep Prabhu; Robert F Paulson; Hong Zheng
Journal:  J Leukoc Biol       Date:  2021-05-31       Impact factor: 4.962

Review 7.  In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts.

Authors:  Eric P Souto; Lacey E Dobrolecki; Hugo Villanueva; Andrew G Sikora; Michael T Lewis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-06-13       Impact factor: 2.698

Review 8.  Recent developments in human immunodeficiency virus-1 latency research.

Authors:  Chi Ngai Chan; Isabelle Dietrich; Margaret J Hosie; Brian J Willett
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

9.  The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment.

Authors:  Elisa Laurenti; Sergei Doulatov; Sasan Zandi; Ian Plumb; Jing Chen; Craig April; Jian-Bing Fan; John E Dick
Journal:  Nat Immunol       Date:  2013-05-26       Impact factor: 25.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.